Hematopoietic cell transplant is a common treatment modality for patients with hematopoietic malignancies as well as other marrow or immune disorders. 1, 2 Treatment protocols are often tailored to the patient's underlying disease as well as health status, with variations including autologous transplant, peripheral blood stem cell transplant, and non-myeloablative transplant. [1] [2] [3] [4] Although some of these current methods of hematopoietic cell transplant tend to be less toxic, many patients still experience significant renal injury because of exposure to a multitude of factors including cytotoxic conditioning agents, radiation, immunosuppression, infection, ischemia, and graft-versus-host disease (GVHD). [5] [6] [7] [8] Acute kidney injury is associated with medications (chemotherapeutic, antibiotic, immunosuppressive), tumor lysis syndrome, renal ischemia, infections, or radiation, whereas chronic kidney injury, including glomerulonephridities, has been associated with chronic GHVD, medications, sequelae of acute injury, ischemia, other comorbidities, and recurrent/secondary malignancy. [7] [8] [9] Numerous descriptive studies, derived from groups of kidney core biopsy specimens from hematopoietic cell transplant recipients with renal dysfunction, have characterized the most common types of glomerulonephritis in hematopoietic cell transplant patients. 8, [10] [11] [12] [13] [14] [15] [16] [17] [18] These include membranous nephropathy, minimal change disease, and focal segmental glomerulosclerosis. In addition, acute and chronic thrombotic microangiopathy, or 'transplant-associated thrombotic microangiopathy,' has been shown to occur commonly in hematopoietic cell transplant recipients, 8, 14, [17] [18] [19] [20] [21] [22] [23] [24] [25] with smaller reported numbers of membranoproliferative glomerulonephritis, proliferative glomerulonephritis, ANCA-associated glomerulonephritis, and IgA nephropathy. 8, 18, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] In studies also examining nonglomerular pathology, kidney specimens also show concomitant tubulointerstitial and vascular changes in hematopoietic cell transplant patients. 8, 14, 16, 19, 38, 39 A few single-center studies of autopsy kidney specimen in the hematopoietic cell transplant population have been reported, including one large study focused primarily on thrombotic microangiopathy. 20, 21, 38, 40 We retrospectively reviewed our single-center experience with renal pathology in specimens from three groups of hematopoietic cell transplant recipients. These included patients with core kidney biopsies for clinical renal dysfunction, in which we characterized three glomerulonephridities not previously reported in the hematopoietic cell transplant population. We also evaluated surgical kidney specimens from hematopoietic cell transplant patients resected for tumor or obstruction, as well as a group of over 40 autopsy kidneys.
Materials and methods
With IRB approval, Department of Pathology files (2009) (2010) (2011) (2012) (2013) (2014) were searched for kidney specimens in patients with a history of hematopoietic cell transplant, including renal biopsy specimens, surgical resections, and autopsy cases. One tumor case from 2000 was also included. None of these cases were included in our prior study. 16 A group of nine consecutive nephrectomies in 2013 for renal cell carcinoma from patients aged 55 years or younger were reviewed as comparative controls for the surgical specimens.
Renal biopsy specimens had been collected and processed using standard procedures for light microscopy (including multiple levels and special stains periodic acid Schiff (PAS), Jones silver, and Trichrome), immunofluorescence microscopy (antibodies to IgG, IgM, IgA, kappa, lambda, C3, C1q, fibrinogen, and, in a few cases, IgG subclasses IgG1, IgG2, IgG3, and IgG4), and electron microscopy as described previously. 16, 41 For surgical resection specimens, in addition to H&E stains, PAS, Jones, and trichrome stains were performed; PAS stains were evaluated for control nephrectomies. For autopsy specimens, an additional PAS stain and C4d immunohistochemistry (described below) was performed on one kidney block per patient. Available light microscopic slides were reviewed with attention to the following parameters: number or percent globally sclerotic glomeruli, glomerular morphology, interstitial inflammation, tubular injury, casts, calcifications, interstitial fibrosis, tubular atrophy, arteriolar and arterial hyaline, and vascular sclerosis.
Immunohistochemical stains were performed in two surgical cases to further characterize glomerular cells using standard immunohistochemical methods on formalin-fixed, paraffin-embedded tissue. CD20, CD3, and CD68 stains were also performed on three control nephrectomies, and C4d immunohistochemical staining was performed on autopsy kidney specimens, as described previously. 42 In one case with granular non-immune deposits, energy-filtered transmission electron microscopy was performed. Energy-filtered transmission electron microscopy imaging was acquired on a Titan Krios (FEI, Hillsboro, OR, USA) at 300 keV, with a Gatan 963 Quantum GIF. Images were acquired on a post-GIF Gatan US4000 CCD. Energy-filtered transmission electron microscopy imaging was achieved using the three-image method. Briefly, three images are acquired at pre-and post-M-N edges, and then background images are subtracted to show the signal from the element of interest (in this case silver).
Clinical data was abstracted from the electronic medical record as available, including clinical renal diagnosis, baseline and current serum creatinine, urinalysis (proteinuria, hematuria), serologies (antinuclear antibody, ANCA, antiglomerular basement membrane, complement C3, C4), viral status (polyomavirus BK, cytomegalovirus, hepatitis), along with treatment and outcome data after kidney biopsy. Hematopoietic cell transplant parameters such as time post-transplant, original disease requiring hematopoietic cell transplant, type of transplant (autologous, allogeneic; marrow, peripheral stem cells, or cord blood), conditioning regimen and prior chemotherapy where available, GVHD history, and prophylaxis/treatment. Statistical analysis was performed with Statview program, or an online calculator (www.socscistatistics.com), using unpaired T-test, χ 2 test, or Fisher's exact test. P-value of 0.05 was considered significant.
Results
To examine kidney pathology in the setting of hematopoietic cell transplant, we reviewed our institutional experience (2009-2014) with histopathologic specimens in the following settings: renal biopsies performed for kidney dysfunction (n = 16 biopsies in 14 patients); resection specimens performed for renal cell carcinoma or obstruction (n = 6); and autopsy (n = 47); each group is described separately below.
Renal Biopsies for Kidney Dysfunction
Over a 5-year time period, we received 16 kidney biopsies for renal dysfunction from 14 patients (Tables 1A and 1B and Supplementary Table 1) . Patients' ages ranged from 8 to 76 years at the time of biopsy, and the time since transplant ranged from 1 month to 21 years. The principal biopsy findings were acute or chronic thrombotic microangiopathy in five patients, minimal change disease (n = 2), focal segmental glomerulosclerosis (n = 3), collapsing glomerulopathy (n = 1), antiglomerular basement membrane disease (n = 1), fibrillary glomerulonephritis (n = 1), amyloidosis (n = 1, presumably recurrent), interstitial nephritis (n = 1), and acute tubular injury (n = 1). Biopsies frequently contained multiple histopathologic abnormalities, including acute tubular injury/necrosis, arteriolar hyalinosis, global glomerulosclerosis, interstitial fibrosis/tubular atrophy, and interstitial inflammation. Two thrombotic microangiopathy cases also demonstrated segmental subepithelial or intramembranous immune deposits (Table 1B and Figures 1a-c). To our knowledge, collapsing glomerulopathy, antiglomerular basement membrane disease, and fibrillary glomerulonephritis have not been previously reported in hematopoietic cell transplant patients, and these cases are described in greater detail below.
Collapsing glomerulopathy. Patient no. 8 received an allogenic bone marrow transplant for chronic granulomatous disease at the age of 15 years, with fludaribine and total body irradiation conditioning. He was of Caucasian race, had biopsy-proven GVHD of the colon, and had cyclosporine exposure. One year after transplant he presented with nephrotic syndrome with a urine protein to creatinine ratio of 37 mg/mg, low serum albumin of 1 g/dl, and a serum creatinine of 0.9 mg/dl, elevated from baseline of 0.6 mg/dl. Renal biopsy demonstrated collapsing glomerulopathy involving 2 of 10 glomeruli sampled for light microscopy ( Figure 1d ), and an additional involved glomerulus was seen in the electron microscopy specimen, which demonstrated diffuse podocyte foot process effacement and glomerular basement membrane collapse; no tubuloreticular structures were identified (Figures 1e and f). Immunofluorescence studies were negative, and immunohistochemical stains were negative for parvovirus, adenovirus, and polyoma virus. There was evidence of tubular injury, with vesicular tubular cytoplasmic change and mitotic figures, but there was no tubular atrophy or interstitial fibrosis. Despite the patient's young age, mild-to-moderate arteriosclerosis was present. Arteriolar hyalinosis was also noted. The patient was treated with steroids, sirolimus, and rituximab, which resulted in sustained clinical resolution of the nephrotic syndrome for 2 years. Then, his urine protein to creatinine ratio increased from 0.5 to 5, with stable serum creatinine of 0.5 mg/dl, and he was rebiopsied. This biopsy demonstrated focal segmental glomerulosclerosis of no special type, along with nearly 40% global glomerulosclerosis and increased interstitial fibrosis and tubular atrophy (Table 1B) .
Anti-GBM disease. Patient no. 12 received an allogenic bone marrow transplant for myelodysplastic syndrome at the age of 63 years (unknown conditioning and prior chemotherapy); he had history of clinical GVHD (lung), but never smoked.
Ten years after transplant he presented with rapidly rising serum creatinine (up to 6.5 mg/dl over 10 days). The renal biopsy showed 10 globally sclerotic glomeruli of 18 sampled. Seven of the remaining glomeruli contained cellular crescents (Figures 1g-i) . Interstitial inflammation was brisk, and tubulitis was present. There was 80-90% interstitial fibrosis and tubular atrophy, with moderate arteriosclerosis. Immunofluorescence demonstrated diagnostic IgG linear glomerular basement membrane staining of 2-3+ intensity (Figure 1i ), along with linear IgG1, κ, and λ. Fibrinogen stained five glomeruli segmentally. Electron microscopy showed thick glomerular basement membranes (500 nm), podocyte foot process effacement, but no deposits. After biopsy, serum antiglomerular basement membrane studies returned positive (reported as 66, reference range: negative o 19 AU/ml; positive 26 AU/ml); and weakly positive antimyeloperoxidase. The patient was started on hemodialysis, and passed away 18 months later.
Fibrillary glomerulonephritis. Patient no. 13 had Hodgkin lymphoma, with proteinuria noted during prior lymphoma relapse, although he had no kidney biopsy before hematopoietic cell transplant. He received an autologous peripheral blood stem cell transplant at the age of 23 years with BEAM conditioning (carmustine, etoposide, cytarabine, melphalan), after previous chemotherapy regimens. Eighteen months after transplant, elevated serum creatinine (2 mg/dl) and proteinuria was noted (urine protein to creatinine ratio of~6). The renal biopsy demonstrated a proliferative glomerulonephritis with crescents, glomerular basement membrane irregularities, and deposit (Figures 1j-l) .
Immunofluorescence was positive with smudgy staining for IgG, IgG1, κ, λ, and C3. Electron microscopy revealed fibrillary deposits with 20-30 μm fibril diameter in mesangial zones and along glomerular basement membranes. Interstitial fibrosis and tubular atrophy were minimal, and arteriosclerosis was mild. The patient was treated with rituximab, with partial renal remission (proteinuria decreased to urine protein to creatinine ratio of 2 mg/mg, serum creatinine o 1 mg/dl) 1 year after biopsy, without evidence of lymphoma recurrence.
Kidney Resection Specimens
Five hematopoietic cell transplant recipients with renal cell carcinoma and one patient with ureteral stricture (ureteral injury during retroperitoneal lymph node dissection) underwent surgical resection (three nephrectomy, three partial nephrectomy) 6 to 23 years after transplant (average 15.7 years; Table 2 and Supplementary Table 1) , markedly longer than the biopsy group. Non-neoplastic renal disease was neither recognized nor clinically investigated in any of the patients with carcinoma before surgery. In the renal cell carcinoma patients, global glomerulosclerosis was variable, and interstitial fibrosis and tubular atrophy was relatively modest, yet vascular changes were striking ( Table 2 .
In glomeruli, all five of the hematopoietic cell transplant patients with renal cell carcinoma had mild segmental mesangial sclerosis or segmental basement membrane duplication (Table 2) . Interestingly, two patients (nos. 16 and 17) had distinctive but difficult to characterize segmental cellular glomerular lesions (Figures 2a-c) involving~10% of glomeruli, and not recognized at the time of initial pathologic evaluation. Patient no. 17 had spot proteinuria of 4300 mg/dl, but proteinuria was not measured in any other patients. The involved segments were expanded by confluent collections of cells with clear cytoplasm and bland nuclei without nucleoli; the underlying glomerular architecture was effaced. There were PAS+ droplets within the epithelioid cells, with intercellular basement membrane material in these segments seen by PAS, Jones, and Trichrome stains.
Immunohistochemical studies were performed to further characterize the intraglomerular cells (Table 2 and Figures 2d-f) ; markers for monocyte/ macrophages (CD68) and mesangial cells (GATA3) were positive in a subset of the cells, whereas endothelial markers (CD31, ERG) stained mostly the periphery of these segments (Table 3) . Lack of staining for PAX2 and CD10 disfavored intraglomerular renal cell carcinoma. Tissue was punched from the formalin-fixed, paraffin-embedded archival blocks and reprocessed for electron microscopy, which demonstrated basement membrane investing large cells, some but not all of which had ultrastructural features suggestive of histiocytes.
Glomeruli in patient nos. 16 and 17 without those segmental lesions were slightly hypercellular and also appeared to contain prominent mononuclear leukocytes in capillary loops, which were further characterized by immunostaining for CD20, CD3, and CD68, in comparison with three control nephrectomy specimens (Table 4 ). As cell counts were similar in transplant and non-transplant nephrectomies, glomerulitis is likely secondary to the surgical procedure or specimen handling.
Renal Pathology in Hematopoietic Cell Transplant Patients at Autopsy
Forty-seven hematopoietic cell transplant recipients underwent autopsy at our center over the 5-year study period. Patients' ages were 1-71 years at autopsy (average 50.3 years). Post-transplant survival ranged from 1 day to 25 years (average 13 months), with 32 patients (68%) deceased within 6 months of transplantation (Table 5 ). Pulmonary disease, including infection, contributed to death in 39 patients (83%); only one patient had leukemia relapse, and another had amyloid at the time of death. Patient and transplantation parameters were widely varied, and are summarized in Table 4 , with data for each patient tabulated in the Supplementary Data section.
The most prevalent glomerular finding in the autopsy cohort was acute thrombotic microangiopathy, seen in 10 patients (21%; five female and five male recipients). Each of these patients received allogeneic stem cells, six were conditioned with total body irradiation, and at least eight had calcineurin inhibitor exposure after transplantation. Patients survived an average of 5.8 months after hematopoietic cell transplant (range 1 month-2 years, with 8 of 10 surviving 6 months or less). In patients with thrombotic microangiopathy, serum creatinine ranged from 0.34 to 2.2 mg/dl and averaged 0.9 mg/dl before death. Cause of death in thrombotic microangiopathy patients included acute lung injury/ diffuse alveolar damage in six patients (some with pulmonary hemorrhage), systemic or pulmonary fungal infection (1-aspergillus, 1-zygomycoses), hemosiderosis, and cerebral infarct with subarachnoid and pulmonary hemorrhage. Glomerular microangiopathic changes were generally seen within only a small fraction of glomeruli and included capillary loops occluded by pale flocculent material, often accompanied by fragmented red blood cells, and occasionally by fibrin in H&E-stained sections (similar to Figure 1a) ; however, autolysis may have Abbreviations: ALL, acute lymphoblastic leukemia/lymphoma; Allo, allogeneic; AML, acute myeloid leukemia; Auto, autologous; BMT, bone marrow stem cell transplant; chemo, cytotoxic chemotherapy (unknown type); cytoxan, cyclophosphamide; GBM, glomerular basement membrane; HCT, hematopoietic cell transplant; MTX, methotrexate; PBSCT, peripheral blood stem cell transplant; TBI, total body irradiation. a Donor cell infusion 5 years prior.
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Renal pathology in stem cell transplant precluded recognition of thrombotic microangiopathy in other instances. Acute thrombotic microangiopathy was not significantly associated with time after transplant, patient age, calcineurin inhibitor exposure, irradiation, type of transplant (allogeneic versus autologous), or clinical GVHD in allogeneic recipients. Segmental glomerular basement membrane duplication was seen in three additional patients, consistent with chronic thrombotic microangiopathy. C4d immunostaining was performed to visualize glomerular deposits in formalin-fixed, paraffinembedded tissue. With this method, we identified two cases (4%) with granular capillary loop staining in the pattern of membranous nephropathy (Figures  3a-c) . Silver staining also demonstrated small minimal-to-marked arteriolar hyalinosis (Figures 3b  and c) . C4d immunostaining also colocalized with hyaline in these and other patients. Flocculent or dense glomerular and arteriolar C4d staining was seen in rare glomeruli in patients with and without thrombotic microangiopathy (Figures 3b and c and  Table 5 ).
Other glomerular pathology included focal segmental glomerulosclerosis in patient no. 35 , who died 2 months after an autologous hematopoietic cell transplant for myeloma, whereas patient no. 38 had evidence of diabetic nephropathy 13 years after an allogeneic peripheral blood hematopoietic cell transplant for chronic myeloid leukemia. Patient no. 64, who was 7 months post-allogeneic peripheral blood stem cell transplant for myelodysplastic syndrome, had distinctive fine black granules lining glomerular and some tubular basement membranes (Figure 3d ), which were even apparent in the paraffin tissue kidney blocks but not in blocks from other organ systems. These did not have the characteristics of immune complex deposit, and were negative on calcium stain. Correlation with the patient history revealed ingestion of a homemade colloidal silver preparation, and a 'bluish-gray tint' to his skin. 43, 44 Electron microscopic examination of reprocessed formalin-fixed, paraffinembedded tissue demonstrated extremely dense small granules (Figure 3e ), and energy-filtered transmission electron microscopy analysis was consistent with silver (argyria, Figure 3f) . 43, 44 Given the nature of the lesions and intervals since transplantation, the glomerular pathology in these cases may not be related to hematopoietic cell transplant.
Non-glomerular infectious and neoplastic renal pathology (Figures 3g and h ) included fungal invasion (patient no. 34, likely Candida sp.), bacterial thrombi (patient no. 61, who had known enterococcus and colitis), vascular amyloid (patient no. 59), and leukemia (patient no. 30, recurrent after autologous transplant). Otherwise, interstitial nephritis was scarce in hematopoietic cell transplant patients at autopsy; focal inflammation was seen in 17/47 cases (36%; Table 4 ).
Although evaluation of renal tubules was hampered by autolysis in the majority of cases, three pediatric and two adult patients had evidence of acute tubular injury/necrosis, with either flattening or vacuolization of tubular epithelial cells (patient nos. 32, 36, 37, 51, and 59), all with elevated serum creatinine. Additionally, seven patients had evidence of sparse oxalate crystals within renal tubules (patient nos. 22, 25, 39, 54, 59, 62, and 64), as may be associated with acute tubular injury, since none of these patients had history of chronic kidney disease or oxalosis.
We also observed paucicellular interstitial fibrosis out of proportion to the degree of tubular atrophy in hematopoietic cell transplant kidneys. This pattern was seen in 22/47 (47%) autopsy patients and showed no significant association with patient age, time after transplant, exposure to irradiation, alkylating agents, calcineurin inhibitors, type of transplant, or clinical GVHD.
Vascular pathology was frequent in hematopoietic cell transplant kidneys. At least moderate arteriosclerosis was noted in 27/47 cases (57%). Patients with arteriosclerosis tended to be older (Figure 4 ), but arteriosclerosis did not appear to correlate with time after transplant or irradiation. Arteriolar hyaline was present in half of hematopoietic cell transplant kidneys (25/47 = 53%), but was generally focal. The presence of hyaline was not correlated with patient age, calcineurin inhibitor exposure, irradiation, type of transplant, or time after transplant.
Discussion
We present our single-institution experience with renal pathology in hematopoietic cell transplant recipients, encompassing not only renal biopsy specimens for dysfunction but also patients without overt clinical renal impairment, including surgical resections for other causes and autopsy specimens. For the first time, we describe collapsing glomerulopathy, antiglomerular basement membrane disease, fibrillary glomerulonephritis, and distinctive but unique segmental cellular and sclerosing glomerular lesions in hematopoietic cell transplant recipients. We also found significant non-glomerular pathology in each group.
Focal segmental glomerulosclerosis has accounted for~6% of glomerular pathology in hematopoietic cell transplant, based on published reports. 8, 11, 14, 16, 18, 39, 45 We encountered focal segmental glomerulosclerosis in 3 of 14 (21%, patient nos. 6-8) patients with renal biopsy. Minimal change disease, also grouped with 'podocytopathies,' is relatively common in hematopoietic cell transplant, 8, 18 and was seen in 2 of 14 biopsied patients (14%); however, to our knowledge, collapsing glomerulopathy has not been previously reported. Interestingly, the Caucasian adolescent boy with collapsing glomerulopathy achieved remission of proteinuria with immunosuppression, but upon proteinuria relapse was found to have focal segmental glomerulosclerosis of no special type. Outside of the study period, we recently encountered another pediatric hematopoietic cell transplant recipient with collapsing focal segmental glomerulosclerosis; this patient had a recent history of thrombotic microangiopathy, and prior exposure to both calcineurin inhibitors and sirolimus.
One hematopoietic cell transplant recipient in our series had antiglomerular basement membrane disease on biopsy. Antiglomerular basement membrane disease in the general population, especially with pulmonary and renal manifestations, has been associated with smoking or exposure to inhaled toxins; it is interesting that this patient had pulmonary GVHD clinically. Exposure of collagen-IV α-3 epitopes as a result of immune-mediated lung injury is a speculative mechanism of antiglomerular basement membrane disease in this hematopoietic cell transplant recipient; however, antiglomerular basement membrane disease has not previously been reported in the hematopoietic cell transplant population, which makes this less likely. It is unclear whether the glomerulonephritis was related to the hematopoietic cell transplant, as it occurred more than 10 years after transplant.
Fibrillary glomerulonephritis is characterized by immunoglobulin deposition in glomeruli, usually polyclonal, that forms deposits with organized substructure, generally randomly oriented fibrils of 10-30 nm diameter. Nasr et al 46 has drawn association of fibrillary glomerulonephritis with malignancy (15/66 patients, 23% in their series), autoimmune disease (10/66, 15%), and other comorbidities, but to our knowledge, it has not been previously reported in the setting of hematopoietic cell transplantation. As this patient's proteinuria before transplant was noted to wax and wane with the course of his Hodgkin lymphoma, there was some concern for lymphoma recurrence after hematopoietic cell transplant. Yet, there was no evidence of malignancy for the year after biopsy, and proteinuria was partially controlled after a course of Rituximab treatment.
The group of patients who underwent kidney resection for malignancy (n = 5) or obstruction (n = 1) allowed 'incidental' analysis of non-neoplastic kidney 6-23 years after transplant in patients without overt renal dysfunction. All five of the patients with renal cell carcinoma had mesangial sclerosis, and two had peculiar cellular glomerular lesions unlike glomerulonephritides reported in native kidney biopsies of the non-hematopoietic cell transplant population, including those with renal cell carcinoma. By immunohistochemistry and electron microscopy, we identified endothelial, mesangial, and macrophage/monocytic cells in these segments, yet a subset of the cellular constituents remained unclassified. We hypothesize that chronic hematopoietic cell transplant-related injury over very long periods of time (11 and 22 years after transplant) contribute to this glomerular pathology. We suspect that such lesions have not been described in prior hematopoietic cell transplant biopsy series given their focality, association with little renal functional impairment, and long post-transplant time course as seen in our series; however, further study is certainly needed, with consideration for the potential interaction of hematopoietic cell transplant and renal cell carcinoma. These findings reinforce the necessity of non-neoplastic kidney assessment in cancer nephrectomies. 47, 48 We compared global glomerulosclerosis, interstitial fibrosis/tubular atrophy, arteriolar hyalinosis, and arteriosclerosis in the surgical hematopoietic cell transplant group with non-transplant patients with renal cell carcinoma under 55 years of age (otherwise unmatched). Global glomerulosclerosis was greater in the hematopoietic cell transplant group (average 26, or 25% excluding patient with obstruction). Vascular pathology was prevalent in both groups, with the hematopoietic cell transplant group having seemingly more severe changes.
Our autopsy cohort afforded another view of renal pathology in patients unselected for renal dysfunction. We found acute thrombotic microangiopathy in 10 (21%) of autopsy patient kidneys, although it was often only seen in rare glomeruli of the involved kidneys. Siami et al 20 reported acute thrombotic microangiopathy in eight of a consecutive series of 20 hematopoietic cell transplant autopsies (40%), while El-Seisi et al 38 reported 12/26 (46%) of transplant patients with acute thrombotic microangiopathy. A large study from the Fred Hutchinson Cancer Center (cohort transplanted 1992-1999) found acute thrombotic microangiopathy in 20% of 314 patients, with isolated thrombi in another 15%. 21 In their study, multivariate analysis identified acute GVHD, donor-recipient sex mismatch (female recipient/male donor), total body irradiation 41200 cGy, and adenovirus infection associated with thrombotic microangiopathy. 21 We did not identify significant clinical associations for thrombotic microangiopathy in our cohort, which was more limited by size, and lack of clinical information for many patients.
Several authors have suggested that interstitial inflammation and tubulitis could represent manifestations of GVHD in autopsy kidney. 23, 38, 40 In their study of 26 autopsy cases, El-Seisi et al 38 noted substantial interstitial fibrosis, as we found in our group, but they also found tubulitis of unspecified degree in 67% of autopsied hematopoietic cell transplant patients, although they did not find an association of tubulitis with clinical GVHD. In a study of seven hematopoietic cell transplant patients with thrombotic microangiopathy, Mii et al 23 noted mild or moderate interstitial inflammation in all patients (two biopsy, five autopsy). We found inflammation in only 36% of autopsied kidneys, mostly quite mild (Table 5) , although a greater proportion of patients biopsied for clinical indication in our series did have interstitial inflammation (9/14, 64%; Table 1B ). The reason for this difference in the autopsy cohorts is not apparent, although the transplantation eras were distinct (1992-2000 ElSeisi, versus majority of patients transplanted after 2005 in our study); nevertheless, interstitial nephritis was not a major finding in our autopsy group.
The utility and potential clinical implications of C4d staining in hematopoietic cell transplant kidney specimens has been a topic of recent interest. 23, 25, 49 We used C4d as a surrogate marker of immune deposits and identified two hematopoietic cell transplant recipients with granular capillary loop deposition, consistent with occult membranous nephropathy. In separate studies, Mii et al, 23, 49 Laskin et al, 25 and Sakamoto et al 50 demonstrated C4d labeling in arterioles and glomeruli of biopsy and autopsy kidney specimens from patients with hematopoietic cell transplant and thrombotic microangiopathy. Mii et al 23, 49 surmised that this finding might provide evidence of antibodymediated pathology, based on analogy with antibody mediation rejection in solid organ transplantation. 49 Subsequently, Laskin et al 25 found arteriolar but not glomerular C4d staining to correlate with histologic thrombotic microangiopathy in patients with both allogeneic and autologous hematopoietic cell transplant. However, neither study included a nonhematopoietic cell transplant thrombotic microangiopathy control group. We observed flocculent, poorly localized staining in rare glomeruli in 28/43 (65%) of hematopoietic cell transplant recipients, including those with and without thrombotic microangiopathy. We also noted C4d staining in arterioles, often in a pattern corresponding to arteriolar hyalinosis (Figures 3b and c) . Other studies and our unpublished observations have identified glomerular C4d reactivity in biopsies with thrombotic microangiopathy or endothelial injury in a variety of clinicopathologic settings, such as lupus-associated thrombotic microangiopathy, hemolytic uremia syndrome, atypical hemolytic uremia syndrome, and allograft glomerulopathy. [51] [52] [53] It remains possible that the observed C4d reactivity could represent nonspecific insudative C-4 accumulation (similar to C3 and IgM in focal segmental glomerulosclerosis and/or hyaline), or complement pathway activation.
In summary, we report renal pathologic findings in contemporary series of renal biopsies, surgical specimens, and autopsy kidneys of hematopoietic cell transplant recipients (n = 67). We describe for the first time in this setting collapsing glomerulopathy, fibrillary glomerulonephritis, antiglomerular basement membrane disease, and peculiar segmental cellular glomerular lesions present in 2/5 hematopoietic cell transplant patients with renal cell carcinoma. As expected, thrombotic microangiopathy was prevalent in hematopoietic cell transplant patients; further, C4d immunohistochemical staining was used to uncover membranous nephropathy in two autopsy patients. Many patients had multiple renal abnormalities, including tubulointerstitial and vascular pathology, along with glomerular changes.
